Tata Chemicals reported income from operations on consolidated basis at Rs. 2,609 crore, up by 11% as compared to Rs. 2,348 crore of June quarter of FY2021. 

 

PAT reported on consolidated basis at Rs. 132 crore, up by 78%, as compared to Rs. 74 crore of the June quarter of FY2021. On a standalone basis, the income from operations rose by 14% to Rs. 717 crore, as compared to Rs. 628 crore of the June quarter of FY2021. PAT on standalone basis was Rs. 135 crore, up by 24%, as compared to Rs. 109 crore for June quarter of FY2021.

 

The company’s results by reporting segment showed income from operations for the Basic Chemistry Products at Rs. 1,839 crore, up by 10% and Specialty Products at Rs. 766 crore, up by 13%, as compared to June quarter of FY2021.

 

Commenting on the results, R Mukundan, Managing Director & CEO, Tata Chemicals said, “With the country gradually reopening, we are witnessing the revival of the chemical sector and customer demand. Our plant operations and capacity utilisation have gained momentum and are getting back to the pre-COVID levels. While we are scaling up our operations and ensuring business continuity, the health and safety of our employees and customers will remain our priority. In the coming quarters, we are aiming to move up the value chain with our business strategy concentrating on four verticals - performance materials, nutritional sciences, agro sciences and energy sciences, while maintaining cash flow and cash balances.”